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Abstract 16 
The brain changes as we age and these changes are associated with functional deterioration 17 
and neurodegenerative disease. It is vital that we better understand individual differences in the 18 
brain ageing process, hence techniques for making individualised predictions of brain ageing 19 
have been developed. We present evidence supporting use of neuroimaging-based brain age 20 
as a biomarker of an individual’s brain health. Increasingly, research is showing how brain 21 
diseases or poor physical health negatively impact brain age. Importantly, recent evidence 22 
shows that having an ‘older’-appearing brain relates to advanced physiological and cognitive 23 
ageing and the risk of mortality. We discuss controversies surrounding brain age and highlight 24 
emerging trends such as the use of multi-modality neuroimaging and the employment of ‘deep 25 
learning’ methods. 26 
27 
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Brain scans can be used to predict age 28 
As the global population ages, the burden of age-associated functional decline and disease is 29 
increasing [1]. Methods are required for predicting who is at higher risk of age-associated 30 
deterioration, how this decline will progress and which treatments are most appropriate. The 31 
ageing process is biologically complex [2], and despite the generally negative effects of ageing, 32 
there is pronounced variation among people in the timing of manifestation of ageing effects  33 
(Figure 1). This variation in brain aging may contribute to the enormous variation in human 34 
lifespan, and in the varying ages at which people develop age-related diseases. Potentially, a 35 
person’s underlying biological age (see Glossary) may differ from their chronological age, and 36 
could be a better indicator of future risk of experiencing age-associated health issues. 37 
Ageing results in marked changes to the structure and function of the brain. Cognitive decline 38 
and an increased risk of neurodegenerative diseases are a key source of the burden caused by 39 
ageing. However, pronounced individual differences are also seen in measures of the brain as 40 
people age [3]. While the average age-driven trajectories of brain volume, cortical thickness and 41 
white matter microstructure have been characterised in healthy people [4-6], a single person 42 
may differ considerably from the average. Potentially, the extent to which someone deviates 43 
from healthy brain ageing trajectories could indicate underlying problems in outwardly healthy 44 
people, and relate to the risk of cognitive ageing or age-associated brain disease. Hence, reliable 45 
biomarkers of brain ageing could be of great neuroscientific and clinical value.  46 
Using structural or functional neuroimaging data, it is now possible to predict age [7, 8]. The 47 
most effective approaches to age prediction have used data from magnetic resonance imaging 48 
(MRI) scans of the brain and run a type of statistical analysis on the images called machine 49 
learning. By ‘learning’ the relationship between patterns of data from brain scans and 50 
chronological age in a training dataset of healthy people, age predictions can be made using 51 
brain images from people not included in the initial training. The most accurate measures in 52 
adults have reported a mean absolute error (MAE) of <5 years [8-12], which can be measured 53 
with high test-retest reliability [9, 13]. Moreover, in studies covering age ranges between early 54 
childhood and young adulthood the most accurate predictions result in MAEs of approximately 55 
only 1 year [14-16].  56 
While using neuroimaging to predict age may be seen as an interesting academic exercise, it is 57 
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also an important proof-of-concept, showing that the information extracted from a single MRI 58 
scan relates strongly to chronological age and that it can be used to make accurate age 59 
estimations in new scans. Furthermore, a growing body of research is demonstrating that so-60 
called brain age has both clinical and broader scientific relevance. This paradigm has provided 61 
a new way to explore how the brain changes during ageing and how brain diseases interact with 62 
‘normal’ brain ageing. Potentially, brain age could be used as a personalised biomarker of brain 63 
health during ageing, and this individual-specific nature is particularly important. The extensive 64 
study of group-mean differences in case-control studies of brain diseases has yielded few clinical 65 
applications. Conversely, brain age locates an individual within a normative ageing distribution. 66 
If this location can be shown to be relevant for health outcomes, then brain age presents a 67 
framework for applying neuroimaging clinically to characterise brain health. Here we outline the 68 
methods for predicting brain age, evaluate evidence for its use as an ageing biomarker and 69 
discuss trends in the ongoing development of the paradigm.  70 
How does neuroimaging-based brain age prediction work? 71 
The accuracy of brain age prediction relies on the fact that the brain changes as we age (Box 1) 72 
and that these changes are reasonably consistent between different people. Neuroimaging 73 
provides a unique window into the brain ageing process, allowing precise and reliable 74 
measurement of many aspects of brain structure and function. Recent advances in computing 75 
and the increasing availability of large neuroimaging datasets mean that researchers have been 76 
enabled to apply machine learning to the problem of age prediction (Figure 2, Key Figure; Box 77 
2).  78 
How does brain age relate to other ageing measures? 79 
The brain can be affected by peripheral physiological changes and having a healthy brain is 80 
essential for overall health. Therefore, measuring brain age could provide a window for general 81 
biological ageing, as a potential ageing biomarker. To that end, it is useful to consider whether 82 
brain age relates to other known facets of ageing. Measures of ageing typically used in 83 
gerontology include physiological, cognitive and biological components. Physiological 84 
measurements of hand-grip strength, lung function, and walking speed are used to characterise 85 
general physical health as well as to predict risk of mortality in older adults [17-19]. Evidently, by 86 
using robust measurements techniques as proxies of underlying physiological variability, 87 
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information about general health and residual lifespan can be obtained. Brain age appears to 88 
meet these criteria, as a recent large-scale study in 73 year-olds found a significant relationship 89 
between brain age and mortality risk, ascertained up to seven years after scanning [20]. For 90 
every year that an individual’s brain was predicted to be older than their chronological age, there 91 
was a 6% increased risk of death. This study also showed that lower grip-strength, lower forced 92 
expiratory volume and a slower walking time were all significantly associated with brain age, as 93 
was a composite measure of fluid cognition. This supports the idea that the brain is sensitive to 94 
general declines in health and suggests that brain age could be used as an ageing biomarker, 95 
to make individualised predictions about mortality risk in older adults. The abovementioned study 96 
also compared brain age to other putative ageing biomarkers. Brain age did not correlate with 97 
either leukocyte telomere length or DNA-methylation age. Interestingly, brain age was a stronger 98 
predictor of mortality than the other measures, though a combined model of brain age with DNA-99 
methylation age was the best predictor, illustrating the benefits of combining distinct ageing 100 
biomarkers. 101 
Brain diseases and brain age 102 
If brain age can provide information about future health outcomes in the general population, this 103 
motivates research into potential causes of deviations from healthy brain ageing. As such, 104 
considering how specific diseases relate to brain age may help isolate deleterious influences on 105 
brain health in later life. Understanding how variability in brain age within diverse clinical samples 106 
relates to other facets of non-communicable and age-related diseases could help identify 107 
individuals at risk of poor health outcomes as ageing and disease processes interact. Potentially, 108 
diseases result in increases to brain ageing, as a one-off ‘hit’ or a progressive acceleration to 109 
the process. Alternatively, the presence of a disease may not cause brain ageing per se, but 110 
occurs on top of underlying individual differences in ‘normal’ brain ageing. This could mean that 111 
the effects of that disease are exacerbated in those with ‘older’ as opposed to ‘younger’ 112 
appearing brains. Either way, measuring brain age in disease groups could be fruitful for 113 
quantifying some of the heterogeneity within a disease, improving identification of individuals at 114 
higher risk of poor health outcomes. Consequently, brain age could be used as general marker 115 
of poorer brain health to help stratify enrolment of individuals into clinical trials of therapies aimed 116 
at improving brain health in older adults, who may not have observable clinical or cognitive 117 
impairments. 118 
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While aetiologically and pathophysiologically distinct, many diseases seem to have common, 119 
secondary effects on the brain. For example, brain injury, multiple sclerosis, major depressive 120 
disorder and Alzheimer’s are all associated with a heightened immune response, 121 
neuroinflammation, oxidative stress, mitochondrial dysfunction and epigenetic alterations [21-122 
30]. Notably, all these phenomena are also implicated in the biology of ‘normal’ ageing [2]. 123 
Furthermore, a number of diseases have been proposed to exacerbate biological ageing, 124 
including Down’s syndrome, HIV and traumatic brain injury [31-33]. Given the relationship 125 
between ageing and disease risk, it is unsurprising that common underlying mechanisms may 126 
be present. However, the availability of ageing biomarkers now allows researchers to evaluate 127 
evidence of abnormal ageing in specific diseases, and in the context of brain diseases, brain 128 
age is likely to be a particularly relevant measure. It is hoped that combining ageing-related 129 
biomarkers with more disease-specific biomarkers will lead to further improvements in diagnostic 130 
and prognostic modelling, moving closer to clinical applications of neuroimaging. 131 
Indeed, a growing number of neuropsychiatric diseases have been associated with increases in 132 
brain age (Table 1). These include traumatic brain injury [34], schizophrenia [12, 35, 36], epilepsy 133 
[37], Down’s syndrome [38], HIV [39], mild cognitive impairment and Alzheimer’s [13, 40-42]. 134 
Similar results have also been seen in peripheral conditions and non-communicable diseases, 135 
such as mid-life obesity [43] and diabetes [44], suggesting again that the brain is also sensitive 136 
to deteriorations in general physical health. These outwardly disparate conditions may share 137 
some common pathological neurobiological components, effects secondary to the disparate 138 
primary pathological processes, that result in an increase in age-associated loss of brain volume. 139 
Interestingly, brain age was more sensitive in showing differences between groups, when 140 
compared to total and regional brain volumes [40]. Methodologically, the variance in brain age 141 
is largely explained by a composite of brain volume, age and sex, though also contains unique 142 
variance not captured by commonly used measures.  Thus, analysing brain age in these contexts 143 
provides a novel way to capture individual differences within the general population as well as 144 
disease groups, which relate to additional facets of various diseases or even predict future 145 
outcomes. For example, increased brain age in people with mild cognitive impairment has been 146 
associated with greater risk of developing Alzheimer’s within three years [40, 42]. 147 
Despite the many different causes of neuropathology, response mechanisms of the brain seem 148 
to be relatively limited, whether the causes are infectious, traumatic or genetic. Hence, the brain 149 
 7 
age studies can be seen as evidence that common secondary mechanisms, observed across 150 
diseases, may relate to those seen in healthy ageing and may be important for some of the 151 
neurological, cognitive and behavioural consequences of brain diseases. In line with this, 152 
cognitive performance has also been assessed in studies of brain age. In general, there are 153 
significant relationships between global cognitive performance and brain age, being more 154 
pronounced in disease samples [10, 13, 15, 20, 34, 39, 40, 42]. This supports the idea that brain 155 
ageing and cognitive ageing are linked, though the modest strength of these associations 156 
suggests that further methods development is needed to better capture the variation in brain 157 
structure and cognitive performance. 158 
Improving individual brain health 159 
While there may be many deleterious influences on brain age, there is also evidence of 160 
protective factors. Significant associations with decreased brain age and markers of good health 161 
in cognitively healthy elderly [45] and the general population [46] have been reported. 162 
Furthermore, the number of years of education and a self-reported measure of physical activity 163 
(number of stairs climbed daily) were reported to be significantly associated with a lower brain 164 
age in individuals aged 19-79 years [47]. Alongside this, recent studies have observed a 165 
reduction in brain age in long-term practitioners of meditation [48] and in amateur musicians [49]. 166 
Although only cross-sectional, such results are promising. They suggest that interventions could 167 
be effective in slowing or potentially even reversing brain ageing, reducing the risk of future 168 
cognitive decline and age-associated disease. However, prospective longitudinal studies of 169 
positive influences on brain age are yet to be conducted. This represents the next, and crucial, 170 
step in developing a framework for evaluating potential treatments of age-associated brain 171 
deterioration. 172 
Controversies around brain age   173 
While the brain age paradigm offers a powerful approach to investigating brain ageing, it has 174 
attracted some criticisms, either technical or philosophical. For instance, some consider the only 175 
factor that affects age to be time, thus ageing per se cannot deviate from its chronological 176 
course. This criticism applies to all potential ageing biomarkers, instead suggesting that in fact 177 
there is limited biological variability in ageing and that deviations are due to specific pathological 178 
processes, not reflecting an extension of ‘normal’ ageing. However, there is strong support for 179 
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the hypothesis that ageing results from cumulative biological damage [50]. It follows from this 180 
that variable exposure to the causes of this cumulative damage would result in individual 181 
differences in rates of underlying biological.  Furthermore, the very fact that ageing is the major 182 
risk for numerous diseases strongly suggests that biological ageing and disease are intrinsically 183 
linked. Beyond this, we argue that whether or not an increased brain age indicates that a brain 184 
is actually ‘older’ is not the chief consideration. If brain age (or other biologically-predicted ages 185 
for that matter) can be a useful neuroscientific and clinical tool then it warrants further 186 
exploration. 187 
Another criticism of brain age is that by condensing whole-brain voxel-wise information into a 188 
single number it is overly ‘black box’. By not scrutinising exactly which features of a brain scan 189 
are used for predicting age, important neuroscientific information may be disregarded and it is 190 
unclear precisely what information age prediction is based on. However, there are several 191 
important reasons why interpreting the ‘weight maps’ derived from machine learning is 192 
complicated and does not offer a straightforward interpretation in the context of brain ageing 193 
[51]. First, no one part of the brain is the sole driver of ageing; brain ageing is a global 194 
phenomenon. Second, age-related changes to the brain are subtle, non-linear, spatially 195 
distributed and vary between individuals [4, 6, 52]. The advantage of the brain age paradigm is 196 
that, by using machine learning, the model can learn a range of different brain structures that 197 
may be healthy. This avoids reductively focusing on the average, which likely is unrepresentative 198 
of any single individual. 199 
A final criticism of brain age is that it relies on using the resulting error in prediction (i.e., the 200 
difference between the predicted age and chronological age) as a metric for further analysis. 201 
Statistically, this is equivalent to using the residuals for an individual from a linear regression 202 
model. Basing clinical or neuroscientific interpretations on error may be semantically dubious, 203 
as in theory more accurate models would reduce this error. Crucially, however, the key to 204 
determining the validity of brain age lies in external validation with other characteristics 205 
measured in the same individuals. For example, the fact that the error metric (e.g., brain-206 
predicted age difference) relates to cognitive performance, ageing fitness and subsequent 207 
survival [13, 15, 20, 40, 42, 47], strongly supports the idea that by quantifying this error, clinically 208 
and biologically meaningful insights can be derived. 209 
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Concluding remarks 210 
The emerging field of brain age prediction is evolving rapidly and an increasing number of 211 
researchers are employing brain age analysis to explore brain ageing in health and disease. A 212 
number of promising trends are developing. These include the combination of multiple 213 
neuroimaging modalities, for example combining structural and functional MRI data, or multiple 214 
structural MRI modalities (T2*, diffusion-MRI), resulting in improved prediction performance [10, 215 
53]. Combined predictors potentially better capture the various facets of brain ageing, including 216 
brain atrophy, iron deposition and alterations to white matter microstructure (see Outstanding 217 
Questions). 218 
Another development is the increasing availability of large datasets. Key to accurate machine 219 
learning is having a sufficient number of examples to learn from. Initiatives such as the 220 
International Neuroimaging Data-Sharing Initiative (INDI; http://fcon_1000.projects.nitrc.org/) 221 
and NeuGrid4U (https://neugrid4you.eu/) encourage sharing existing datasets. Ground-breaking 222 
projects like the Human Connectome Project and UK Biobank have been explicitly designed to 223 
share data and are making unprecedented amounts of neuroimaging data accessible. 224 
Important for leveraging these larger and more complex datasets is innovation in computational 225 
statistics, to optimise algorithms for predicting brain age [54]. In particular, deep learning 226 
methods show particular promise [9]. The ‘hidden’ layers in deep learning allow data-driven 227 
representation of different global and local data features, meaning that hitherto unknown 228 
relationships can be more accurately identified. One benefit particular to neuroimaging is the 229 
removal the reliance on data pre-processing to extract meaningful features. Such features are 230 
automatically encoded by the deep neural network, avoiding the model-dependent decisions 231 
used in image pre-processing (e.g., registration algorithm, template selection). While the 232 
computational demands for deep learning are high, the added benefits likely outweigh the costs, 233 
and deep learning might enjoy increasing interest in brain age analysis, as in other neuroimaging 234 
research. 235 
The ability to predict a person’s brain age using neuroimaging data is increasingly providing 236 
insights into both positive and negative effects on age-associated brain changes, and is 237 
shedding new light on how diseases affect the ageing brain. Furthermore, brain age has the 238 
potential to identify individuals at risk of experiencing advanced biological ageing, and thus could 239 
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provide a biomarker of age-associated health problems. As the technical aspects of brain age 240 
analysis are further developed, the possibility that neuroimaging-based measures of brain age 241 
could be used to evaluate neuroprotective preventions and therapeutics comes closer to being 242 
realised. 243 
  244 
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Glossary  366 
(411/450 words) 367 
Ageing biomarker: A biological measurement that gives an estimate of an organism’s biological 368 
age, based on the biological age of an organ, tissue or cell. 369 
Biological age: The hypothetical underlying age of an organism, defined by measuring some 370 
aspect of the organism’s biology. Biological age may differ from the organism’s chronological 371 
age and be a better indicator of residual lifespan, functional capacity and risk of age-associated 372 
changes. 373 
Brain age (or brain-predicted age): The predicted age of an individual, derived using high-374 
dimensional neuroimaging data in a machine-learning framework. Brain age potentially 375 
represents a biomarker of the underlying ‘age’ of the brain, whereby an ‘older’ brain in adults 376 
indicates increased risks for neurodegenerative diseases and mortality. 377 
Brain ageing: Changes to the human brain that generally accompany ageing. These changes 378 
occur at molecular, cellular and tissue levels, and have characteristic functional and behavioural 379 
consequences (Box 1). 380 
Deep learning: An extension of machine learning, based on artificial neural networks. ‘Deep’ 381 
refers to the multiple layers of neural networks used, including one or more ‘hidden’ layers. Each 382 
layer is used to transform input data into a different format that encodes something salient about 383 
the features contained in the data. 384 
Feature: A variable used in a machine learning algorithm, or an aspect of a dataset that is of 385 
some relevance. In the context of brain age, features are local measures of brain structure or 386 
function (e.g., grey matter volume). 387 
Gerontology: The scientific study of the old and the ageing process. 388 
Machine learning: A statistical approach derived from the study of artificial intelligence, based 389 
on the concept that statistical models should be able to make accurate predictions from new 390 
‘unseen’ data (either categorical, e.g., group membership, or continuous, e.g., age, IQ). 391 
Magnetic Resonance Imaging (MRI): A medical imaging technique that capitalises on the 392 
inherent physical properties of biological tissues when inside powerful magnetic fields. 393 
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Particularly, hydrogen atoms contained in water within biological tissue behave in characteristic 394 
ways when the magnetic fields are manipulated and release energy in the form of radiofrequency 395 
(RF) pulses that can be recorded. These RF pulses can be transformed into three-dimensional 396 
images that give information on brain volume, blood flow, brain function, white matter 397 
microstructure to name but a few biological characteristics. 398 
Voxel: A volume-element, the three-dimensional equivalent of a pixel. Voxels are the unit of 399 
resolution for MRI scans of the brain. 400 
Weight maps: Voxel-wise maps of the brain, where each voxel contains a numeric 401 
representation of the statistical model learned by a machine learning algorithm. 402 
  403 
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Text Boxes 404 
Box 1. Brain ageing and its consequences  405 
(292/400 words) 406 
Age-related changes in the human brain are characterised by region-specific and non-linear 407 
patterns of highly coordinated and sequenced events of progressive (e.g., cell growth and 408 
myelination) and regressive (e.g., synaptic pruning) processes during development [55] and 409 
wide-spread atrophy during ageing [56]. In fact, grey matter volume decreases steadily 410 
throughout adulthood, while white matter volume follows an inverted ‘U-shape’ curve, peaking 411 
in midlife [56, 57]. Underlying these macroscopic atrophic changes are a whole host of molecular 412 
and cellular events. These include altered calcium signalling, genomic alterations, reductions to 413 
synaptogenesis and neurite outgrowth, demyelination, microglial activation and subsequent 414 
inflammatory responses, changes to cellular metabolism and mitochondrial dysfunction and 415 
eventual astrocytic hypertrophy and reduced neuronal activity [58]. These biological changes 416 
have behavioural consequences. Most characteristic is the decline in cognitive function 417 
commonly observed across adulthood (i.e., cognitive ageing). While memory impairments are 418 
most recognised, performance decrements are seen in the majority of cognitive domains, with 419 
only crystallised intelligence spared [59]. While the precise relationship between cognitive 420 
ageing and the neurophysiological changes in the brain is still unclear, the presence of some 421 
link between the two is intuitive [60]. Beyond cognitive ageing, advanced brain ageing is also 422 
associated with an increased prevalence of brain diseases, particularly neurodegenerative 423 
diseases, including Alzheimer’s, Parkinson’s and Amyotrophic Lateral Sclerosis, to name a few. 424 
In fact, age is the biggest risk factor for many of these diseases, and the progressive nature of 425 
these conditions means that severity worsens with age. The dementia that results from many of 426 
these diseases causes a high burden on society and on individuals, both financially and socially. 427 
Currently, there are limited options for modifying or treating these diseases, and even evaluating 428 
potential therapeutics is difficult as the relatively slow rates of disease progression make long-429 
term interventional studies challenging. 430 
Box 2. How brain age prediction works  431 
(396/400 words) 432 
The general analytic ‘pipeline’ for predicting the biological age of individual brains uses structural 433 
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neuroimaging from a large sample of healthy people, screened to exclude those with 434 
neuropsychiatric or physical health conditions. The chronological age of these individuals is 435 
known and they should represent the adult lifespan. These individuals comprise the so-called 436 
‘training set’. The following stages are carried out: 1) Neuroimaging data from the training set 437 
then usually undergoes image pre-processing to derive meaningful features that relate to ageing, 438 
for example spatial registration to a template, to quantify brain volume at each voxel. 2) These 439 
features are then used as predictors or independent variables in a regression model, with 440 
chronological age as the outcome or dependent variable. This is the inverse to conventional 441 
statistical approaches that aim to understand which brain regions may have a linear relationship 442 
with age, as in voxel-based morphometry. Ordinary least-squares (OLS) regression models are 443 
inappropriate for such high-dimensional neuroimaging datasets, where each individual is 444 
characterized by several hundred or thousand datapoints. Hence, multivariate machine-learning 445 
methods (e.g., support vector, relevance vector or Gaussian Processes regression) are used, 446 
as they were designed to cope with high-dimensional types of data. 3) The accuracy of the 447 
machine learning regression model is assessed using a cross-validation procedure. Popular 448 
variations of this include k-fold and split-half cross-validation. The idea behind cross-validation 449 
is that some proportion of the individuals in the training set is left out of the initial ‘learning’ stage. 450 
The parameters of the learned model (analogous to OLS beta estimates) are then applied to the 451 
pre-processed data of the left-out individuals, resulting in brain-derived predictions of age. This 452 
age prediction is then compared to the known chronological age of each left-out individual. 453 
Accuracy metrics, including the Pearson correlation between the predicted and chronological 454 
ages, the R2 (i.e., variance explained) of the prediction model and the mean absolute error 455 
(MAE), are then generated to evaluate the specific age prediction model. 4) Assuming the brain 456 
age prediction model reaches a desired level of accuracy, entirely new individuals (‘test set’) can 457 
now be run through the model, generating individual predictions of brain age. The difference 458 
between predicted and chronological age quantifies the acceleration or deceleration in individual 459 
brain ageing. For example, if the brain age of a 70 year-old results in a difference of +5 years, 460 
this individual shows the typical atrophy pattern of a 75 years old. 461 
  462 
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Figure Legends 463 
Figure 1. Trajectories of biological ageing 464 
As chronological age increases, there is a trend towards a higher risk of diseases and the onset 465 
of cognitive decline. This trend is thought to have a biological basis, relating to the cumulative 466 
damage to cells and tissues acquired over time. While people who are generally healthy (grey 467 
arrow) reach the threshold for symptoms to appear at approximately a similar age, other people 468 
may follow different trajectories of biological ageing. This could be due to genetic differences, or 469 
exposure to environmental effects that subtly increase the rate at which age-associated damage 470 
accumulates (blue arrow). Potentially, people may experience pronounced environmental 471 
influences, such as a brain injury or cerebral infection, leading to a marked acceleration of the 472 
rate of biological ageing (red line). In the current context, brain age may represent a measure of 473 
the underlying biological age of the brain. By measuring how far an individual is from the healthy 474 
brain ageing trajectory, researchers hope to be able to quantify advanced and decelerated brain 475 
ageing and use this to predict individual’s future trajectories and subsequent risk of age-476 
associated health deterioration. 477 
Figure 2. How brain age prediction works 478 
Overview of the brain age prediction process, using ‘supervised’ machine learning. A) 479 
Neuroimaging data, usually T1-weighted structural MRI scans, from healthy individuals (training 480 
set) are labelled with the participants’ chronological age and put into a machine learning 481 
regression model. B) To validate the accuracy of the model, a proportion of participants’ images 482 
are left out of the model. For example, ten-fold cross-validation involves training the model on 483 
90% of participants and predicting age values on the left-out 10%. This is then iterated through 484 
all participants, and predicted values are compared with real values (i.e., chronological age) to 485 
assess accuracy. C) Assuming the model is sufficiently accurate, the model is trained using the 486 
entire training set and the resulting model coefficients applied to new participants’ brain scans 487 
(test set) to generate unbiased individual brain age predictions, in this example 61.7 years. D) 488 
The predicted brain age can then be compared with the chronological age of test set participants, 489 
with ‘older’ appearing brains assumed to reflect advanced brain ageing and ‘younger’ appearing 490 
brains to reflect decelerated or healthy brain ageing. The discrepancy between brain age and 491 
chronological age (brain-predicted age difference) can then be used as a metric to statistically 492 
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relate to other measured characteristics of the participants. 493 
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Tables 501 
Table 1. Studies assessing brain age in neurological and psychiatric diseases 502 
Clinical group N Age mean (SD) Features for brain age Mean brain age difference (years) References 
Alzheimer’s disease 102 76 (8) GM 10.0 Franke, 2010 [8] 
Alzheimer’s disease 150 75 (8) GM 
baseline: 6.7 
follow-up (2y): 9.0 
Franke, 2012 [13] 
Alzheimer’s disease 
(APOE 4 carriers/non-carriers) 
101 / 49 74 (7) / 76 (9) GM 
baseline: 5.8 / 6.2 
follow-up (2y): 8.3 / 7.7 
Löwe, 2016 [42] 
Alzheimer’s disease 411 75 (7) Hippocampus 7 Li, 2017 [61] 
At-risk mental states for psychosis 89 25 (6) GM 1.7  Koutsouleris, 2013 [35] 
Bipolar disorder 22 38 (11) GM 
-1.3  
(males: -1.9 / females: -0.8) 
Nenadic, 2017 [36] 
Borderline personality disorder 57 26 (7) GM 3.1  Koutsouleris, 2013 [35] 
Diabetes mellitus type 2 98 65 (8) GM 4.6 Franke, 2013 [44] 
Diabetes mellitus type 2 12 63 (7) GM 
baseline: 5.1  
follow-up (4y): 5.9 
Franke, 2013 [44] 
Down’s syndrome 46 42 (9) Whole brain 2.5 Cole, 2017 [38] 
Epilepsy  
(medically-refractory/newly-diagnosed) 
94 / 42 32 (14) / 31 (11) Whole brain 4.5 / 0.9 Pardoe, 2017 [37] 
HIV 162 56 Whole brain  2.2 Cole, 2017 [39] 
Major depression 104 42 (8) GM 4.0  Koutsouleris, 2013 [35] 
Mild cognitive impairment, progressive 112 74 (7) GM 
baseline: 6.2 
follow-up (3y): 9.0 
Franke, 2012 [13] 
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Mild cognitive impairment, progressive 
(early/late) 
58 / 75 74 (7) / 75 (7) GM 8.7 / 5.6 Gaser, 2013 [40] 
Mild cognitive impairment, progressive 
(APOE 4 carriers / non-carriers) 
78 / 34 74 (6) / 75 (9) GM 
baseline: 5.8 / 5.5 
follow-up (3y): 8.7 / 7.3 
Löwe, 2016 [42] 
Mild cognitive impairment, stable 36  77 (6)  GM 
baseline: -0.5  
follow-up (3y): -0.4  
Franke, 2012 [13] 
Mild cognitive impairment, stable 
(APOE 4 carriers/non-carriers) 
14 / 22 77 (6) / 77 (6) GM 
baseline: -0.9 / -0.9 
follow-up (3y): 0.0 / -0.6 
Löwe, 2016 [42] 
Obesity 227 58 (17) WM 10 Ronan, 2016 [43] 
Objective cognitive impairment 
(mild/major) 
632 / 251 58 (15) / 58 (16) Whole brain (multimodal) 0.7 / 1.7 Liem, 2017 [10] 
Schizophrenia 141 28 (12) GM 5.5  Koutsouleris, 2013 [35] 
Schizophrenia 341 34 (12) GM 
baseline: 3.4 
follow-up (4y): 4.3 
Schnack, 2016 [12] 
Schizophrenia 45 34 (10) GM 2.6 (males: 3.4 / females: 1.1) Nenadic, 2017 [36] 
Traumatic brain injury 99 38 (12) GM / WM 4.7 / 6.0 Cole, 2015 [34] 
Features for brain age are reported as the aspect of brain structure used predictors in the brain-age model. GM = grey matter, WM = white 503 
matter. Data formats include voxelwise 3D images or summary measures of cortical thickness and subcortical volumes. Multi-modal refers 504 
to a combination of structural and function MRI. 505 
